{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:38Z","timestamp":1786118918264,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.jcrs.2007.07.046","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T15:17:55Z","timestamp":1196867875000},"page":"2098-2105","source":"Crossref","is-referenced-by-count":50,"title":["Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema"],"prefix":"10.1097","volume":"33","author":[{"given":"Fernando J.","family":"Arevalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael A.","family":"Garcia-Amaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan G.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihteh","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria H.","family":"Berrocal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-35-20210210","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0002-9394(53)90302-X","article-title":"A newly defined vitreous syndrome following cataract surgery; interpreted according to recent concepts of the structure of the vitreous; the Seventh Francis I. Proctor Lecture.","volume":"36","author":"Irvine","year":"1953","journal-title":"Am J Ophthalmol"},{"key":"R3-35-20210210","first-page":"262","article-title":"Chronic cystoid macular edema and predictors of visual acuity.","volume":"24","author":"Spaide","year":"1993","journal-title":"Ophthalmic Surg"},{"issue":"4","key":"R4-35-20210210","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0896-1549(02)00041-X","article-title":"Update on pseudophakic cystoid macular edema treatment options.","volume":"15","author":"Levin","year":"2002","journal-title":"Ophthalmol Clin North Am"},{"key":"R5-35-20210210","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0039-6257(84)90226-1","article-title":"Cystoid macular edema in pseudophakia.","volume":"28","author":"Stark","year":"1984","journal-title":"Surv Ophthalmol"},{"key":"R6-35-20210210","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000073070","article-title":"Incidence of cystoid macular edema after uncomplicated phacoemulsification.","volume":"217","author":"Mentes","year":"2003","journal-title":"Ophthalmologica"},{"key":"R7-35-20210210","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/S0886-3350(99)00196-0","article-title":"Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity.","volume":"25","author":"Ursell","year":"1999","journal-title":"J Cataract Refract Surg"},{"key":"R8-35-20210210","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0039-6257(04)00109-2","article-title":"Macular edema.","volume":"49","author":"Tranos","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"R9-35-20210210","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0886-3350(99)00159-5","article-title":"Pseudophakic cystoid macular edema treated with high-dose intravenous methylprednisolone.","volume":"25","author":"Abe","year":"1999","journal-title":"J Cataract Refract Surg"},{"key":"R10-35-20210210","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0161-6420(97)30065-7","article-title":"A comparison of retrobulbar versus sub-Tenons corticosteroid therapy for cystoid macular edema refractory to topical medications.","volume":"104","author":"Thach","year":"1997","journal-title":"Ophthalmology"},{"key":"R11-35-20210210","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1395-3907.2003.0146.x","article-title":"Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema.","volume":"81","author":"Karacorlu","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"R12-35-20210210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0886-3350(02)01441-4","article-title":"Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema.","volume":"29","author":"Conway","year":"2003","journal-title":"J Cataract Refract Surg"},{"key":"R13-35-20210210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1442-9071.2006.01213.x","article-title":"Use of a cyclo-oxygenase 2 inhibitor for prophylaxis of cystoid macular oedema following cataract surgery: a randomized placebo-controlled trial.","volume":"34","author":"Riley","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"key":"R14-35-20210210","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/bjo.2005.073817","article-title":"Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review.","volume":"89","author":"Sivaprasad","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R15-35-20210210","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/S0886-3350(03)00233-5","article-title":"Treatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolac.","volume":"29","author":"Rho","year":"2003","journal-title":"J Cataract Refract Surg"},{"key":"R16-35-20210210","first-page":"127","article-title":"A direct correlation of the resolution of pseudophakic cystoid macular edema with acetazolamide therapy.","volume":"23","author":"Tripathi","year":"1991","journal-title":"Ann Ophthalmol"},{"key":"R17-35-20210210","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2005.12.030","article-title":"Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.","volume":"141","author":"Grover","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R18-35-20210210","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0886-3350(89)80089-6","article-title":"Neodymium:YAG laser anterior vitreolysis for Irvine-Gass cystoid macular edema.","volume":"15","author":"Steinert","year":"1989","journal-title":"J Cataract Refract Surg"},{"key":"R19-35-20210210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0886-3350(87)80127-X","article-title":"Preliminary report on the effect of hyperbaric oxygen on cystoid macular edema.","volume":"13","author":"Pfoff","year":"1987","journal-title":"J Cataract Refract Surg"},{"key":"R21-35-20210210","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0002-9394(14)72159-2","article-title":"Pars plana vitrectomy for chronic pseudophakic cystoid macular edema.","volume":"120","author":"Harbour","year":"1995","journal-title":"Am J Ophthalmol"},{"issue":"suppl 1","key":"R22-35-20210210","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/S0039-6257(02)00294-1","article-title":"Prostaglandins and cystoid macular edema.","volume":"47","author":"Miyake","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"R23-35-20210210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00417-004-1087-4","article-title":"Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion.","volume":"244","author":"Noma","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R24-35-20210210","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress.","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"R25-35-20210210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0002-9394(01)01381-2","article-title":"Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate.","volume":"133","author":"Tolentino","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R26-35-20210210","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"R27-35-20210210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006982-200603000-00004","article-title":"Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.","volume":"26","author":"Spaide","year":"2006","journal-title":"Retina"},{"key":"R28-35-20210210","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ophtha.2005.02.007","article-title":"Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration; twelve-week results of an uncontrolled open-label clinical study.","volume":"112","author":"Michels","year":"2005","journal-title":"Ophthalmology"},{"key":"R29-35-20210210","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"R30-35-20210210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-200603000-00005","article-title":"Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion; a short-term study.","volume":"26","author":"Iturralde","year":"2006","journal-title":"Retina"},{"key":"R31-35-20210210","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00006982-200603000-00018","article-title":"Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema.","volume":"26","author":"Mason","year":"2006","journal-title":"Retina"},{"key":"R32-35-20210210","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00006982-200603000-00002","article-title":"Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin).","volume":"26","author":"Shahar","year":"2006","journal-title":"Retina"},{"key":"R33-35-20210210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00006982-200603000-00001","article-title":"Testing intravitreal toxicity of bevacizumab (Avastin).","volume":"26","author":"Manzano","year":"2006","journal-title":"Retina"},{"key":"R35-35-20210210","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ajo.2006.06.068","article-title":"Vascular endothelial growth factor is a critical stimulus for diabetic macular edema.","volume":"142","author":"Nguyen","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R36-35-20210210","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/01.iae.0000247165.38655.bf","article-title":"Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.","volume":"26","author":"Haritoglou","year":"2006","journal-title":"Retina"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335007016136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335007016136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.jcrs.2007.07.046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:55:51Z","timestamp":1786035351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02158034-200712000-00035"}},"subtitle":["Pilot study of the Pan-American Collaborative Retina Study Group"],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2007.07.046","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}